Australia markets closed

Aurobindo Pharma Limited (AUROPHARMA.BO)

BSE - BSE Real-time price. Currency in INR
Add to watchlist
1,466.35+8.55 (+0.59%)
At close: 03:29PM IST
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/03/2024
31/03/2023
31/03/2022
31/03/2021
Assets
Current assets
Cash
Cash and cash equivalents
33,934,800
43,962,900
41,625,100
53,734,700
Other short-term investments
29,316,900
18,273,400
3,951,300
2,477,300
Total cash
63,251,700
62,236,300
45,576,400
56,212,000
Net receivables
48,167,400
44,663,800
40,122,600
35,032,800
Inventory
98,082,300
85,112,300
75,538,500
90,265,700
Other current assets
25,364,300
18,687,000
15,550,100
14,488,100
Total current assets
242,056,300
215,456,700
181,226,900
198,235,100
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
207,843,800
183,629,500
146,379,400
93,155,100
Accumulated depreciation
-63,726,900
-55,593,500
-38,680,300
-31,457,100
Net property, plant and equipment
144,116,900
128,036,000
107,699,100
93,155,100
Goodwill
5,951,500
5,960,700
4,754,200
4,289,000
Intangible assets
34,814,600
33,258,500
31,378,700
26,907,000
Other long-term assets
2,299,600
45,300
100
4,326,500
Total non-current assets
208,658,800
183,443,200
157,990,300
140,304,800
Total assets
450,715,100
398,899,900
339,217,200
338,539,900
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
41,803,200
42,425,600
25,512,500
48,037,800
Accounts payable
44,541,600
38,713,100
27,030,500
27,946,800
Other current liabilities
2,803,300
2,235,900
1,279,400
5,561,900
Total current liabilities
121,991,300
114,937,800
81,559,800
106,650,500
Non-current liabilities
Long-term debt
21,349,000
6,189,600
2,492,100
1,684,900
Deferred tax liabilities
3,565,600
3,896,100
4,109,600
5,745,600
Deferred revenues
363,500
0
-
-
Other long-term liabilities
364,700
-15,153,200
297,700
395,000
Total non-current liabilities
30,215,800
15,443,600
11,916,900
12,599,500
Total liabilities
152,207,100
130,381,400
93,476,700
119,250,000
Stockholders' equity
Common stock
585,900
585,900
585,900
585,900
Retained earnings
268,014,200
240,130,300
225,190,100
201,367,600
Total stockholders' equity
298,428,000
268,398,500
245,759,800
219,298,700
Total liabilities and stockholders' equity
450,715,100
398,899,900
339,217,200
338,539,900